Skip to main content

Table 1 Baseline characteristics of 1197 colorectal cancer patients by diabetes mellitus and non- Ddiabetes mellitus status

From: The impact on clinical outcome of high prevalence of diabetes mellitus in Taiwanese patients with colorectal cancer

Characteristic

Diabetes (%)

Non-diabetes (%)

P value

 

N = 283 (23.6%)

N = 914 (76.4%)

 

Age (mean ± SD)

67.63 ± 10.55

63.11 ± 13.45

< 0.001

Gender

   

 Male/Female

157 (55.5)/126 (45)

516 (56.5)/398 (43.5)

0.772

Tumor size

   

 ≥5 cm/<5 cm

116 (41)/167 (59)

404 (44.2)/510 (55.8)

0.315

Tumor location

   

 Colon/Rectum

199 (70.3)/84 (29.7)

629 (68.8)/285 (31.2)

0.633

Histological type

   

 Well/Moderately/Poorly

23 (8.1)/230 (81.3)/30 (10.6)

68(7.4)/747(81.8)/99(10.8)

0.582

AJCCa Stage

   

 I/II/III/IV

52(18.3)/109(38.5)/85(30)/37(13.2)

155(17)/316(34.6)/280(30.6)/163(17.8)

0.396

Tumor depth

   

 T1/T2/T3/T4

20(7.0)/43(15.2)/210(74.2)/10(3.6)

61(6.7)/136(14.9)/652(71.3)/67(7.1)

0.305

Lympho Nodes metastases

   

 N0/N1/N2

171(60.4)/76(26.9)/36(12.7)

523(57.2)/233(25.5)/158(17.3)

0.322

Vascular invasion

   

 Yes/No

95 (33.6)/188 (66.4)

614 (67.2)/300 (32.8)

0.764

Perineurial invasion

   

 Yes/No

102 (36)/181 (64)

344 (37.6)/570 (62.4)

0.689

Serum Albumin level

   

 <3.5 gm/dl/≥3.5 gm/dl

127 (44.9)/156 (55.1)

349 (38.2)/565 (61.8)

0.018

Pre-op Serum CEAb level

   

 ≥5 ng/ml/<5 ng/ml

160 (56.6)/123 (43.5)

400 (43.8)/514 (56.2)

< 0.001

Post-op Serum CEAb level

   

 ≥5 ng/ml/<5 ng/ml

93 (32.9)/190 (67.1)

245 (26.8)/669 (73.2)

0.024

Cardiac disease

   

 Yes/No

173 (61.1)/110 (38.9)

311 (34)/603 (66)

< 0.001

Pulmonary disease

   

 Yes/No

4 (1.4)/279 (98.6)

12 (1.3)/902 (98.7)

0.898

Renal disease

   

 Yes/No

15 (5.3)/268 (94.7)

40 (4.4)/874 (95.6)

0.517

Second Primary Cancer

   

 Yes/No

27 (9.5)/256 (90.5)

55 (6)/859 (94)

0.040

Chemotherapy

   

 Yes/No

185 (65.4)/98 (35.6)

607 (66.4)/307 (33.6)

0.756

Body Mass Index (mean ± SD)

24.36 ± 3.65

23.29 ± 3.75

< 0.001

  1. a AJCC American Joint Commission on Cancer.
  2. b CEA Carcinoembryonic antigen.
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us